The molecular basis of virus crossreactivity and neutralisation after immunisation with optimised chimeric peptides mimicking a putative helical epitope of the measles virus hemagglutinin protein

Molecular Immunology

Volumn 35, Issue 14-15, 1998, Pages 905-918

  Kasmi, Karim C El ^a,b   Theisen, Dietmar ^a   Brons, Nicolaas H C ^a   Muller, Claude P ^a,b  

^a LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

B cell epitope; Measles virus; Neutralisation; Synthetic peptides; T cell epitope

Indexed keywords

MEASLES VACCINE; VIRUS HEMAGGLUTININ;

ANIMAL EXPERIMENT; ARTICLE; CROSS REACTION; DOWN REGULATION; FEMALE; IMMUNOGENICITY; IMMUNOREGULATION; MALE; MEASLES VACCINATION; MEASLES VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; B-LYMPHOCYTES; CROSS REACTIONS; EPITOPES; FEMALE; HEMAGGLUTININS, VIRAL; IMMUNIZATION; IMMUNOGLOBULIN G; MALE; MEASLES VIRUS; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES;

ANIMALIA; MEASLES VIRUS;

EID: 0031701032     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(98)00087-X     Document Type: Article

References (60)

1. Abaza M.S., Atassi M.Z. J. Protein Chem. 11:1992;677-686.
2. Albrecht P., Ennis F.A., Saltzman E.J., Krugman S. J. Pediatr. 91:1977;715-718.
3. Alkhatib G., Briedis D.J. Virology. 150:1986;479-490.
4. Armah G.E., Nishikawa S., Miki S., Omata Y., Nakabayashi T., Tomita K. Mol. Biochem. Parasitol. 38:1990;135-140.
5. Bachmann M.F., Hengartner H., Zinkernagel R.M. J. Immunol. 25:1995;3445-3451.
6. Bartz R., Brinckmann U., Dunster L.M., Rima B., Ter Meulen V., Schneider-Schaulies J. Virology. 224:1996;334-337.
7. Benjamin D.C., Berzofsky J.A., East I.J., Gurd F.R., Hannum C., Leach S.J., Margoliash E., Michael J.G., Miller A., Prager E.M. Annu. Rev. Immunol. 2:1984;67-101.
8. Brons N.H., Blaich A., Wiesmüller K.H., Schneider F., Jung G., Muller C.P. J. Immunol. 44:1996;478-484.
9. Cox J.H., Ivanyi J., Young D.B., Lamb J.R., Syred A.D., Francis M.J. J. Immunol. 18:1988;2015-2019.
10. Demotz S., Lanzavecchia A., Eisel U., Niemann H., Widmann C., Corradin G. J. Immunol. 142:1989;394-402.
11. Denton G., Hudecz F., Kajtar J., Murray A., Tendler S.J., Price M.R. Pept. Res. 7:1994;258-264.
12. Deroo, S., El Kasmi, K.C., Fournier, P., Theisen, D., Brons, N.H.C., Herrman, M., Desmet, J., Muller, C.P., 1998. Enhanced antigenicity of a four-contact-residue epitope of the measles virus hemagglutinin protein by phage display libraries: evidence of a helical structure in the putative active site.(Mol. Immunol., in press).
13. Dintzis H.M., Dintzis R.Z., Vogelstein B. Proc. Natl. Acad. Sci. USA. 73:1976;3671-3675.
14. Enomoto A., Shon D.H., Aoki Y., Yamauchi K., Kaminogawa S. Mol. Immunol. 27:1990;581-586.
15. Fernandez I.M., Snijders A., Benaissa-Trouw B.J., Harmsen M., Snippe H., Kraaijeveld C.A. J. Virol. 67:1993;5843-5848.
16. Fournier P., Brons N.H., Berbers G., Wiesmüller K.H., Fleckenstein B.T., Schneider F., Jung G., Muller C.P. J. Gen. Virol. 78:1997;1295-1302.
17. Garenne M., Leroy O., Beau J.P., Sene I. Lancet. 338:1991;903-907.
18. Geysen H.M., Barteling S.J., Meloen R.H. Proc. Natl. Acad. Sci. USA. 82:1985;178-182.
19. Giraudon P., Wild T.F. Virology. 144:1985;46-58.
20. Golvano J., Lasarte J.J., Sarobe P., Gullon A., Prieto J., Borras-Cuesta F. J. Immunol. 20:1990;2363-2366.
21. Gras-Masse H., Jolivet M., Drobecq H., Aubert J.P., Beachey E.H., Audibert F., Chedid L., Tartar A. Mol. Immunol. 25:1988;673-678.
22. Hackett C.J., Hurwitz J.L., Dietzschold B., Gerhard W. J. Immunol. 135:1985;1391-1394.
23. Hawkins R.E., Russell S.J., Baier M., Winter G. The interaction of mutant D. 234:1993;958-964.
24. Hirabayashi Y., Fukuda H., Kimura J., Miyamoto M., Yasui K. J. Virol. 61:1996;23-36.
25. Huiss S., Damien B., Schneider F., Muller C.P. Clin. Exp. Immunol. 109:1997;416-420.
26. Jackson D.C., Tang X.L., Brown L.E., Murray J.M., White D.O., Tregear G.W. Virology. 155:1986;625-632.
27. Langedijk J.P., Daus F.J., van Oirschot J.T. J. Virol. 71:1997;6155-6167.
28. Leclerc C., Sedlik C., Lo-Man R., Charlot B., Rojas M., Deriaud E. J. Immunol. 25:1995;2533-2538.
29. Lelievre D., Hsu S.C., Daubos P., Favard C., Vigny P., Trudelle Y., Steward M.W., Delmas A. Eur. J. Biochem. 249:1997;895-904.
30. Levely M.E., Mitchell M.A., Nicholas J.A. Cell Immunol. 125:1990;65-78.
31. Marguerite M., Bossus M., Mazingue C., Wolowczuk I., Gras-Masse H., Tartar A., Capron A., Auriault C. Mol. Immunol. 29:1992;793-800.
32. Martineau P., Leclerc C., Hofnung M. Mol. Immunol. 1345:1996;1358.
33. Meloen R.H., Puyk W.C., Meijer D.J., Lankhof H., Posthumus W.P., Schaaper W.M. J. Gen. Virol. 68:1987;305-314.
34. Merrifield R.B. Adv. Enzymol. Relat. Areas Mol. Biol. 32:1969;221-296.
35. Milich D.R., Jones J.E., McLachlan A., Bitter G., Moriarty A., Hughes J.L. J. Immunol. 144:1990;3544-3551.
36. Moroder L., Musiol H.J., Kocher K., Bali J.P., Schneider C.H., Guba W., Muller G., Mierke D.F., Kessler H. Eur. J. Biochem. 212:1993;325-333.
37. Muller C.P., Bünder R., Mayser H., Ammon S., Weinmann M., Brons N.H.C., Schneider F., Jung G., Wiesmüller K.H. Mol. Immunol. 32:1995;37-47.
38. Muller C.P., Beauverger P., Schneider F., Jung G., Brons N.H. J. Gen. Virol. 76:1995;1371-1380.
39. Neuberger M.S., Rajewsky K. J. Immunol. 1012:1981;1016.
40. Norrby E., Hammarskjold B. Microbios. 5:1972;17-29.
41. Obeid O.E., Partidos C.D., Steward M.W. J. Gen. Virol. 74:1993;2549-2557.
42. Obeid O.E., Partidos C.D., Howard C.R., Steward M.W. J. Virol. 69:1995;1420-1428.
43. Parker D.C. Annu. Rev. Immunol. 11:1993;331-360.
44. Partidos C.D., Steward M.W. J. Gen. Virol. 71:1990;2099-2105.
45. Pulli T., Lankinen H., Roivainen M., Hyypia T. Virology. 240:1988;202-212.
46. Ravetch J.V., Kinet J.P. Annu. Rev. Immunol. 91:1991;457-492.
47. Rehe G.T., Katona I.M., Brunswick M., Wahl L.M., June C.H., Mond J.J. J. Immunol. 20:1990;1837-1842.
48. Roehrig J.T., Johnson A.J., Hunt A.R., Beaty B.J., Mathews J.H. J. Virol. 66:1992;3385-3390.
49. Sabin A.B. Eur. J. Epidemiol. 7:1991;1-22.
50. Sakurai T., Ametani A., Nakamura Y., Shimizu M., Idota T., Kaminogawa S. Int. Immunol. 5:1993;793-800.
51. Sinigaglia F., Guttinger M., Kilgus J., Doran D.M., Matile H., Etlinger H., Trzeciak A., Gillessen D., Pink J.R. Nature. 336:1988;778-780.
52. Snijders A., Benaissa-Trouw B.J., Snippe H., Kraaijeveld C.A. J. Gen. Virol. 73:1992;2267-2272.
53. Tulchinsky T.H., Ginsberg G.M., Abed Y., Angeles M.T., Akukwe C., Bonn J. Bull. World Health Organ. 71:1993;93-103.
54. Vacchio M.S., Berzofsky J.A., Krzych U., Smith J.A., Hodes R.J., Finnegan A. J. Immunol. 143:1989;2814-2819.
55. Varsanyi T.M., Utter G., Norrby E. J. Gen. Virol. 65:1984;355-366.
56. Vijayakrishnan L., Sarkar S., Roy R.P., Rao K.V. J. Immunol. 159:1997;1809-1819.
57. Weiss R. Science. 258:1992;546-547.
58. Wiesmüller K.H., Spahn G., Handtmann D., Schneider F., Jung G., Muller C.P. J. Gen. Virol. 73:1992;2211-2216.
59. Wortis H.H., Teutsch M., Higer M., Zheng J., Parker D.C. Proc. Natl. Acad. Sci. USA. 92:1995;3348-3352.
60. Ziegler D., Fournier P., Berbers G.A., Steuer H., Wiesmüller K.H., Fleckenstein B., Schneider F., Jung G., King C.C., Muller C.P. J. Gen. Virol. 77:1996;2479-2489.